Your browser doesn't support javascript.
loading
LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation.
Wu, Ying; Yu, Dan-dan; Hu, Yong; Cao, Hai-xia; Yu, Shao-rong; Liu, Si-wen; Feng, Ji-feng.
Affiliation
  • Wu Y; The First Clinical School of Nanjing Medical University, Nanjing, China.
  • Yu DD; The First Clinical School of Nanjing Medical University, Nanjing, China.
  • Hu Y; The Fourth Clinical School of Nanjing Medical University, Nanjing, China.
  • Cao HX; Department of Chemotherapy, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, China.
  • Yu SR; Department of Chemotherapy, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, China.
  • Liu SW; The Fourth Clinical School of Nanjing Medical University, Nanjing, China.
  • Feng JF; Department of Chemotherapy, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, China. Electronic address: jifengfeng187@163.com.
Biochem Biophys Res Commun ; 467(4): 900-5, 2015 Nov 27.
Article in En | MEDLINE | ID: mdl-26471306

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Protein Kinase Inhibitors / Proto-Oncogene Proteins c-akt / Orphan Nuclear Receptors / ErbB Receptors / Lung Neoplasms Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2015 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Protein Kinase Inhibitors / Proto-Oncogene Proteins c-akt / Orphan Nuclear Receptors / ErbB Receptors / Lung Neoplasms Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2015 Type: Article Affiliation country: China